Hi Syb and Ahjay,
Not completely unexpected. See slide 9 of the July EGM presentation.
They did say it was coming by end of 2015, but not what the specific disease being targeted was.
Melanoma is a perfect first target in the Sunshine State of the skin cancer capital of the world.
Good to see they are delivering on product development timeline promises. That's an improvement on the past.
Ann: Prima unveils Phase I combination study of IMP321, page-7
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.0¢ |
Change
0.005(1.27%) |
Mkt cap ! $581.0M | |||
| Open | High | Low | Value | Volume |
| 38.5¢ | 41.0¢ | 38.5¢ | $993.7K | 2.494M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 49 | 217843 | 39.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.0¢ | 232952 | 28 |
View Market Depth
| Last trade - 15.01pm 03/09/2024 (20 minute delay) ? |
| IMM (ASX) Chart |